"The cannabis business has arrived at a critical moment. Customers are increasingly seeking the same "proven consistency" that they expect from potato chips and soap. The financial stakes are clear: Despite lingering prohibitions in 17 states, legal cannabis is already an $8 billion industry in the United States. Domestic sales of alcohol, humankind's other favorite intoxicant, topped $200 billion last year. But to make cannabis as popular as booze requires solving that original problem: It's hard to imagine millions of people becoming new recreational users without being able to promise them that the product they're spending money on will give them the effect they want."
There has been a lack of cannabinoid research due to years of prohibition. Scientists are just beginning to scratch the surface on the potential of the 100 different (possibly more) cannabinoids of the cannabis plant.
Homo sapiens have a long, beneficial, and evolutionary relationship with cannabis, according to Dr. Sunil K. Aggarwal, a physician, medical geographer, and co-founder of the Advanced Integrative Medical Science Institute in Seattle.
Cannabis is a chemical powerhouse, with over 500 different compounds, including 100 cannabinoids, found within one plant. While CBD and THC are the most common cannabinoids, others are starting to make a splash. CBG (cannabigerol) has been called the "mother of all cannabinoids" because it can be converted into various other cannabinoids. Potential health benefits from CBG could include the management of pain, sleep, blood pressure, inflammation, anxiety, and gut health.